Biden faces pressure to distribute vaccines worldwide, but Americans still need them at home
stripes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stripes.com Daily Mail and Mail on Sunday newspapers.
Innovation can be extremely unequal.
Mike Cohen/Getty Images
Bill Gates speaks at New York Times Dealbook in 2019.
“No” is probably not a word the world’s second-richest man is all that accustomed to hearing. Bill Gates, one might imagine, exists in a world of near-limitless possibility. When he throws money at things, they often happen: from an elaborate meal prepared by personal chefs to a revolution in personal computing. Why should the climate crisis be any different?
In the press tour for his new book,
How to Avoid a Climate Disaster, Gates has presented himself as having put his big engineer brain to work devising the path to solving climate change, shrugging off the fact that the politics haven’t caught up. It’s an audacious title for a book with a relatively limited scope. The core argument is that the world urgently needs to lower what he calls “Green Premiums”: the extra costs associated with no-carbon energy and other technologies as opposed to more po
Brittney Way Discover More
Angela Castañeda, anthropology professor, is the co-author of an article, “Practising Intimate Labour: Birth Doulas Respond during COVID-19, which was recently published in the journal Anthropology in Action.
Seth Friedman, associate professor of communication and theatre and director of the Film Studies Program, is the author of a peer-reviewed article, “Beyond the Infinite Interpretations: The Reception of 2001: A Space Odyssey and the Reframing of Stanley Kubrick’s Authorial Reputation,” which appeared in the journal Film History.
Seonguk Kim, assistant mathematics professor, wrote a chapter titled “Solutions of Gross-Pitaevskii Equation with Periodic Potential in Dimension Two” for the book, “Analysis as a Tool in Mathematical Physics.” He also is the co-author of a peer-reviewed article, “Global Dynamics of the Stochastic Shadow Gierer-Meinhardt System with Robin Boundary Condition,” which appe
Presage Biosciences raises $13M and inks new deal with Merck for cancer drug tests
March 4, 2021 at 3:30 pm
Presage CEO Richard Klinghoffer. (Presage Photo)
New funds, new partners: Seattle’s Presage Biosciences announced $13 million in funding as well new collaborations with biotech giant Merck and California-based Maverick Therapeutics. Presage is a biotech device company that has built a platform for testing new cancer drugs used to treat tumors.
Presage has existing partnerships with healthcare heavy hitters Takeda Pharmaceutical, Celgene and Bristol Myers Squibb (BMS). The company has raised a total of $35 million in equity, and this its first venture round.
Quicker, cheaper drug screening: Before a cancer drug is given to patients in phase I trials, it’s first tested in the lab. But many of the drugs that appear to hold promise in that setting don’t perform well when marshaled against actual tumors in people.
vimarsana © 2020. All Rights Reserved.